The landscape of dementia analysis has developed dramatically with the arrival of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-based mostly assessments which can detect Alzheimer's pathology years prior to indicators arise. When these technological innovations represent outstanding progress in knowing neurodegenerative cond